Similar articles

• Germ-cell mutations in mice: standards for protecting the human genome.

  Ehling UH. Ehling UH. Mutat Res. 1989 May;212(1):43-53. doi: 10.1016/0027-5107(89)90021-3. Mutat Res. 1989. PMID: 2725541 No abstract available.
• Molecular dosimetry as a tool in genetic risk assessment.

  Aaron CS. Aaron CS. Birth Defects Orig Artic Ser. 1988;24(5):53-78. Birth Defects Orig Artic Ser. 1988. PMID: 3073818 Review. No abstract available.
• Assessment of heritable mutations--the parallelogram approach.

  Wright AS. Wright AS. Mutat Res. 1995 Aug;330(1-2):13-21. doi: 10.1016/0027-5107(95)00032-e. Mutat Res. 1995. PMID: 7623864 Review. No abstract available.
• Correction for differences in germ cell stage sensitivity in risk assessment.

  Lee WR, Kelley MR. Lee WR, et al. Prog Clin Biol Res. 1986;208:99-102. Prog Clin Biol Res. 1986. PMID: 3083428 No abstract available.
• Identifying germ cell mutagens using OECD test guideline 488 (transgenic rodent somatic and germ cell gene mutation assays) and integration with somatic cell testing.

  Marchetti F, Aardema MJ, Beevers C, van Benthem J, Godschalk R, Williams A, Yauk CL, Young R, Douglas GR. Marchetti F, et al. Mutat Res Genet Toxicol Environ Mutagen. 2018 Aug;832-833:7-18. doi: 10.1016/j.mrgentox.2018.05.021. Epub 2018 May 29. Mutat Res Genet Toxicol Environ Mutagen. 2018. PMID: 30057023